EUVIMEDEUVIMED entdecken
Crossref

Carrier-Free Nanoadjuvant-Loaded Bilayer Microneedles for Programmed and Individualized Cancer Chemo-Immunotherapy

Chenlu Huang, Hanyong Wang, Xinyu Yang, Hai Wang, Wen Li iD, Linhua Zhang iD, Dunwan Zhu iD

Nano Letters · 2025

DOI: 10.1021/acs.nanolett.5c02670 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nano Letters, 2025. Verfasst von Chenlu Huang und 6 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Advanced Medical Materials and Devices, Tianjin Key Laboratory of Biomedical Materials, Key Laboratory of Biomaterials and Na…. Hauptthemen laut MEDLINE: Doxorubicin, Triple Negative Breast Neoplasms, Immunotherapy, Adjuvants, Immunologic. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: EPSRC CDT MRes/PhD Studentship in Nanoscience and Nanotechnology, Trinity-Henry Barlow Scholarship, European Union under the Horizon 2020 Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Triple-negative breast cancer (TNBC) exhibits low response rates to current immunotherapies. In this study, we present a double-layer dissolvable microneedle (MN) patch consisting of chemotherapeutic drugs in the shell layer and a carrier-free nanoadjuvant in the core for boosted chemo-immunotherapy. The rapid release of doxorubicin (DOX) elicits immunogenic cell death (ICD) to induce the production of tumor-associated antigens (TAAs). Subsequently, the carrier-free nanoadjuvants are sustainably released for capturing TAAs and generating personalized nanovaccines in situ. The controlled, on-demand biphasic release of chemodrug and nanoadjuvant is proved highly effective in suppressing the growth of tumors and potentiating the antitumor immune response. Ultimately, combining MN patches and antiprogrammed cell death protein-1 (aPD-1) results in a more pronounced therapeutic response. Our work introduces a double-layer detachable MN patch as an implanted microreservoir for copackaging and biphasic release of drugs with distinct therapeutic effects, offering a promising avenue for advanced synergistic immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DoxorubicinTriple Negative Breast NeoplasmsImmunotherapyAdjuvants, ImmunologicCancer VaccinesHumansFemaleAnimalsNeedlesMiceCell Line, TumorAntigens, NeoplasmImmunogenic Cell Death

Stichwörter der Autor:innen

chemo-immunotherapymicroneedle patchesovercome immunosuppressive tumor microenvironmentpersonalized tumor vaccineprogrammed drug release

Substanzen

DoxorubicinAntigens, NeoplasmAdjuvants, ImmunologicCancer Vaccines

Autor:innen und Institutionen

  • State Key Laboratory of Advanced Medical Materials and Devices, Tianjin Key Laboratory of Biomedical Materials, Key Laboratory of Biomaterials and Nanotechnology for Cancer Immunotherapy, Institute of Biomedical Enginee…

ORCID-Profile: Wen Li, Linhua Zhang, Dunwan Zhu

Förderung

  • EPSRC CDT MRes/PhD Studentship in Nanoscience and Nanotechnology
  • Trinity-Henry Barlow Scholarship
  • European Union under the Horizon 2020 Program
  • Lundbeck Foundation
  • Novo Nordisk Foundation to the Center for Multifunction Biomolecular Drug Design
  • Natural Science Foundation of Tianjin Municipality
  • National Natural Science Foundation of China
  • Noncommunicable Chronic Diseases-National Science and Technology Major Project

Zitieren

APA

Huang, C., Wang, H., Yang, X., Wang, H., Li, W., Zhang, L., & Zhu, D. (2025). Carrier-Free Nanoadjuvant-Loaded Bilayer Microneedles for Programmed and Individualized Cancer Chemo-Immunotherapy. Nano Letters. https://doi.org/10.1021/acs.nanolett.5c02670

Vancouver

Huang C, Wang H, Yang X, Wang H, Li W, Zhang L, et al. Carrier-Free Nanoadjuvant-Loaded Bilayer Microneedles for Programmed and Individualized Cancer Chemo-Immunotherapy. Nano Letters. 2025. doi:10.1021/acs.nanolett.5c02670

BibTeX
@article{Huang2025,
  author = {Huang, Chenlu and Wang, Hanyong and Yang, Xinyu and Wang, Hai and Li, Wen and Zhang, Linhua and Zhu, Dunwan},
  title = {Carrier-Free Nanoadjuvant-Loaded Bilayer Microneedles for Programmed and Individualized Cancer Chemo-Immunotherapy},
  journal = {Nano Letters},
  year = {2025},
  doi = {10.1021/acs.nanolett.5c02670}
}
Kostenlos starten →